Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.

Saved in:
Bibliographic Details
Title: Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
Authors: Parsons, H.A.1,2,3 (AUTHOR) Heather_Parsons@dfci.harvard.edu, Blewett, T.1,4 (AUTHOR), Chu, X.5 (AUTHOR), Sridhar, S.4 (AUTHOR), Santos, K.1 (AUTHOR), Xiong, K.4 (AUTHOR), Abramson, V.G.6 (AUTHOR), Patel, A.1 (AUTHOR), Cheng, J.4 (AUTHOR), Brufsky, A.7 (AUTHOR), Rhoades, J.4 (AUTHOR), Force, J.8 (AUTHOR), Liu, R.4 (AUTHOR), Traina, T.A.9 (AUTHOR), Carey, L.A.10 (AUTHOR), Rimawi, M.F.11 (AUTHOR), Miller, K.D.12 (AUTHOR), Stearns, V.13 (AUTHOR), Specht, J.14 (AUTHOR), Falkson, C.1,15 (AUTHOR)
Source: Annals of Oncology. Oct2023, Vol. 34 Issue 10, p899-906. 8p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2023.08.004